News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,389 Results
Type
Article (39598)
Company Profile (310)
Press Release (652481)
Section
Business (204862)
Career Advice (2012)
Deals (35496)
Drug Delivery (91)
Drug Development (81069)
Employer Resources (168)
FDA (16139)
Job Trends (14870)
News (345981)
Policy (32564)
Tag
Academia (2548)
Alliances (49592)
Alzheimer's disease (1289)
Approvals (16099)
Artificial intelligence (159)
Bankruptcy (356)
Best Places to Work (11618)
Biotechnology (217)
Breast cancer (202)
Cancer (1490)
Cardiovascular disease (119)
Career advice (1677)
CAR-T (105)
Cell therapy (309)
Clinical research (65016)
Collaboration (554)
Compensation (302)
COVID-19 (2563)
C-suite (130)
Data (1458)
Diabetes (186)
Diagnostics (6211)
Earnings (85135)
Employer resources (146)
Events (110826)
Executive appointments (461)
FDA (16893)
Funding (505)
Gene therapy (213)
GLP-1 (618)
Government (4349)
Healthcare (18755)
Infectious disease (2659)
Inflammatory bowel disease (116)
Interviews (309)
IPO (16409)
Job creations (3660)
Job search strategy (1430)
Layoffs (430)
Legal (7901)
Lung cancer (220)
Manufacturing (215)
Medical device (13237)
Medtech (13242)
Mergers & acquisitions (19322)
Metabolic disorders (488)
Neuroscience (1642)
NextGen: Class of 2025 (6541)
Non-profit (4483)
Northern California (1852)
Obesity (277)
Opinion (189)
Patents (130)
People (56924)
Phase I (20253)
Phase II (28641)
Phase III (21325)
Pipeline (602)
Postmarket research (2562)
Preclinical (8583)
Radiopharmaceuticals (238)
Rare diseases (280)
Real estate (5939)
Regulatory (21825)
Research institute (2320)
Resumes & cover letters (350)
Southern California (1596)
Startups (3618)
United States (16418)
Vaccines (574)
Weight loss (192)
Date
Today (128)
Last 7 days (873)
Last 30 days (2142)
Last 365 days (35173)
2025 (1351)
2024 (35369)
2023 (40183)
2022 (51289)
2021 (55835)
2020 (54158)
2019 (46646)
2018 (35125)
2017 (32228)
2016 (31631)
2015 (37709)
2014 (31455)
2013 (26502)
2012 (28772)
2011 (29427)
2010 (27525)
Location
Africa (716)
Arizona (202)
Asia (37575)
Australia (6147)
California (4192)
Canada (1531)
China (353)
Colorado (189)
Connecticut (199)
Europe (80535)
Florida (587)
Georgia (141)
Illinois (412)
Indiana (238)
Maryland (674)
Massachusetts (3240)
Michigan (180)
Minnesota (312)
New Jersey (1171)
New York (1188)
North Carolina (779)
Northern California (1852)
Ohio (152)
Pennsylvania (987)
South America (1096)
Southern California (1596)
Texas (604)
Utah (118)
Washington State (426)
692,389 Results for "mosaic biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
Press Releases
Mosaic Biosciences Expands Executive Leadership Team to Drive Growth and Innovation in Drug Discovery
October 30, 2024
·
3 min read
Business
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc.
Mosaic ImmunoEngineering, Inc today announced the signing of a binding term-sheet with Oncotelic Therapeutics, Inc.
April 29, 2024
·
6 min read
BioMidwest
Mosaic Biosciences Expands Its Leading Drug Discovery and Development Expertise
Mosaic Biosciences announced two strategic leadership additions to its team: Malavi Madireddi, PhD, as Senior Vice President, Drug Discovery, and Scott Glaser, PhD, as Senior Vice President, Biologics Discovery.
April 2, 2024
·
4 min read
Business
Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO
Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.
June 27, 2024
·
3 min read
BioMidwest
The Mosaic Company Unveils Mosaic Biosciences™ to Expand Offerings in Plant Health
The Mosaic Company announced the formation of the Mosaic Biosciences™ platform, a global initiative to bring the latest science and innovation to the agriculture market.
August 15, 2023
·
2 min read
Drug Development
Project Mosaic Launches to Bring “Biopsies” to ALS Drug Development
August 21, 2024
·
3 min read
Biotech Bay
Factorial Biotechnologies Unveils Mosaic™: Enabling Single-Cell Analysis Across All Omic Applications
Factorial Biotechnologies, a leader in next-generation single-cell NGS solutions, unveils Mosaic™, a groundbreaking technology poised to empower researchers to delve deeper into cellular heterogeneity than ever before.
February 5, 2024
·
3 min read
Press Releases
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference
January 14, 2025
·
1 min read
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
1 of 69,239
Next
